SCHEMBL15393599

SCHEMBL15393599

CCC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 19/20 0.81
AURKA O14965 12/20 0.81
CCNA2 P20248 8/20 0.80
CDK4 P11802 5/20 0.80
CDK6 Q00534 4/20 0.80
GAK O14976 1/20 0.80
BUB1 O43683 1/20 0.80
CCNT1 O60563 1/20 0.80
ULK1 O75385 1/20 0.80
STK16 O75716 1/20 0.80
PRKD3 O94806 1/20 0.80
LATS1 O95835 1/20 0.80
ABL1 P00519 1/20 0.80
EGFR P00533 1/20 0.80
NTRK1 P04629 1/20 0.80
LCK P06239 1/20 0.80
FYN P06241 1/20 0.80
CDK1 P06493 1/20 0.80
YES1 P07947 1/20 0.80
LYN P07948 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13852057 0.91 CDK2 (0.85) CDK2AURKACCNA2CDK4CDK6
Potassium SCHEMBL4155030 0.90 CDK2 (0.84) CDK2AURKACCNA2CDK4CDK6
SCHEMBL4155017 0.90 CDK2 (0.84) CDK2AURKACCNA2CDK4CDK6
SCHEMBL4169115 0.90 CDK2 (1.00) CDK2AURKACCNA2CDK4CDK6
SCHEMBL4154141 0.89 CDK2 (0.79) CDK2AURKACCNA2CDK4CDK6
Milciclib SCHEMBL619139 0.89 CDK2 (1.00) CDK2AURKACCNA2CDK4CDK6
Potassium Ion SCHEMBL31326946 0.89 CDK2 (0.82) CDK2AURKACCNA2CDK4CDK6
Potassium Ion SCHEMBL4155023 0.89 CDK2 (0.82) CDK2AURKACCNA2CDK4CDK6
Milciclib SCHEMBL4149977 0.88 CDK2 (0.98) CDK2AURKACCNA2CDK4CDK6
Milciclib SCHEMBL29435042 0.85 CDK2 (0.91) CDK2AURKACCNA2CDK4CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9464090-B2 Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2016-10-11 US disclosed
US-8586598-B2 CDK inhibitor salts NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2013-11-19 US disclosed